live-attenuated delta-gD2 based viral vaccine (X-Vax Technology)

N/A

Report date: 2025/01/26 18:05:38

Base Information

Drug Namelive-attenuated delta-gD2 based viral vaccine (X-Vax Technology)
Drug Alias Namedelta gD-2live-attenuated delta-gD2 based viral vaccine (Albert Einstein College)mutated gD2-based viral vaccine (Albert Einstein College)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlbert Einstein College Of Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesX-Vax Technology Inc
Inactive CompaniesAlbert Einstein College Of Medicine Inc
Active IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A